- UroToday Home
- Recent Abstracts
- Urologic Oncology
Investigative Urology
Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer - Abstract
November 18, 2011
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer - Abstract
November 17, 2011
Effect of membrane toxin 12 isolated from Naja naja atra on proliferation and invasion of human bladder cancer EJ cells - Abstract
November 17, 2011
Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy - Abstract
November 17, 2011
Identification of docetaxel resistance genes in castration-resistant prostate cancer - Abstract
November 17, 2011
Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients - Abstract
November 17, 2011
HNF1B polymorphism associated with development of prostate cancer in Korean patients - Abstract
November 16, 2011
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models - Abstract
November 16, 2011
C-reactive protein as a biomarker for urological cancers - Abstract
November 16, 2011
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence - Abstract
November 15, 2011
Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer - Abstract
November 15, 2011
GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells - Abstract
November 15, 2011
Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1 - Abstract
November 14, 2011
MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer - Abstract
November 14, 2011
Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer - Abstract
November 14, 2011
Polyunsaturated fatty acid metabolism in prostate cancer - Abstract
November 14, 2011